Investing.comQwen · 实盘不做把握 2/10不做原因:无增量信息
北京时间·🕒 发布 20:40:34·⟳ 抓取 20:41:14 +40s·⚡ 决策 08-31 20:56:33 +15m19s·57.1 天前
OneMedNet宣布与AI药物开发公司达成去标识化临床数据供应协议
同一具体催化（OneMedNet与AI药物开发公司的数据供应协议）已在72小时内被两条先前决策处理：①12:39 UTC判定本次协议未披露金额/客户/期限，无法量化弹性；②12:43 UTC确认核心1150万美元协议已于2026年7月28日由公司一手披露，本条属旧催化再传播。本条Investing.com AI生成稿件无任何新增事实，不改变结论。
📄 原文Investing.com↗ 原文
OneMedNet secures AI drug development data agreement
Oil jumps 3% as U.S. strikes on Iran revive Hormuz supply disruption concerns MINNEAPOLIS - OneMedNet Corporation (NASD…
不做 OneMedNet Corporation（ONMD.US）
同一具体催化（数据供应协议）已在72小时内被两条先前决策处理并均判定不做：核心协议7月28日已一手披露，本条无新增金额/客户/指引，属旧催化再传播，不构成可交易的新增事实。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Investing.com转述OneMedNet与AI药物开发公司的数据供应协议，但该协议核心内容（1150万美元监管级数据供应）已于7月28日由公司官方披露，6月10日亦已披露2026年新增booking超300万美元。本条稿件无新增金额、客户或指引信息，属于旧催化通过聚合站再传播，不构成可交易的新增事实。
🔎 新鲜度:最早出现 2026-07-28 · 扩散 medium · price-in 风险 high ↗
先例如何影响了这次决策
对本次决策的影响:因判定为重复消息/旧催化再传播，无需先例研究
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 633 ms
{"result": "search_processed_events:agent query=`onemednet irwd platform clinical data deal | onemednet onmd data agreement ai drug development`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 71.7/72 小时、1109 条本臂决策(完整)，返回 2 条候选。\n• 08-31 12:43 UTC(CST 20:43) [ticker] 不做 ONMD.US,PLTR.US (news_center) — OneMedNet secures AI
原文全文
展开原文 · 1,777 字
Oil jumps 3% as U.S. strikes on Iran revive Hormuz supply disruption concerns
MINNEAPOLIS - OneMedNet Corporation (NASDAQ:ONMD) announced today an agreement to provide de-identified clinical real-world data to an AI-driven drug development company, according to a press release statement.
The company’s iRWD platform completed cohort feasibility within minutes, data validation within a week, and contract signing within three weeks of initial contact. The data will support the development and validation of AI models for drug discovery and development.
OneMedNet provides first-party data sourced directly from healthcare providers. The company’s network includes more than 2,300 healthcare partner sites, encompassing over 90 million patient journeys and 270 million studies.
"Healthcare innovators are coming to OneMedNet because they see what it takes to build AI that performs in the real world: private clinical data sourced directly from healthcare providers," said Aaron Green, President and CEO of OneMedNet.
The agreement delivers regulatory decision-grade quality data, including de-identified medical imaging and clinical records. OneMedNet’s multimodal data spans radiology, cardiology, EEG, ECG, and other diagnostic modalities, alongside de-identified electronic health records.
OneMedNet Corporation operates a real-world data platform that delivers de-identified medical imaging and clinical records. The platform is powered by Palantir Foundry and serves life sciences companies, medical device manufacturers, and AI developers. The company’s services support applications including drug development, regulatory submissions, and AI model training.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
MINNEAPOLIS - OneMedNet Corporation (NASDAQ:ONMD) announced today an agreement to provide de-identified clinical real-world data to an AI-driven drug development company, according to a press release statement.
The company’s iRWD platform completed cohort feasibility within minutes, data validation within a week, and contract signing within three weeks of initial contact. The data will support the development and validation of AI models for drug discovery and development.
OneMedNet provides first-party data sourced directly from healthcare providers. The company’s network includes more than 2,300 healthcare partner sites, encompassing over 90 million patient journeys and 270 million studies.
"Healthcare innovators are coming to OneMedNet because they see what it takes to build AI that performs in the real world: private clinical data sourced directly from healthcare providers," said Aaron Green, President and CEO of OneMedNet.
The agreement delivers regulatory decision-grade quality data, including de-identified medical imaging and clinical records. OneMedNet’s multimodal data spans radiology, cardiology, EEG, ECG, and other diagnostic modalities, alongside de-identified electronic health records.
OneMedNet Corporation operates a real-world data platform that delivers de-identified medical imaging and clinical records. The platform is powered by Palantir Foundry and serves life sciences companies, medical device manufacturers, and AI developers. The company’s services support applications including drug development, regulatory submissions, and AI model training.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。